Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
Many people, especially older adults, vegetarians, or those with certain health conditions, may not get enough of it
[PMID: 7011800] PubMed record related to this compound for laboratory literature review
For example, a patient with chronic tendon pain may need imaging, physical therapy, load management, nutrition support, and a diagnosis before any peptide conversation makes sense
SARM1 regulates NAD(+)-linked metabolism and select immune genes in macrophages